Wealth Plan Partners, LLC Astrazeneca PLC Transaction History

Wealth Plan Partners, LLC

$745 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$63.15 - $71.6 $5.35 Million - $6.07 Million	-84,727 Reduced 98.53%	1,260 $87.5 Million
Q4 2022 Feb 16, 2023	BUY	$54.21 - $70.44 $576,469 - $749,058	10,634 Added 14.11%	85,987 $6.05 Billion
Q1 2022 May 03, 2022	BUY	$55.72 - $67.12 $79,846 - $96,182	1,433 Added 1.94%	75,353 $5 Million
Q3 2021 Dec 09, 2021	SELL	$55.56 - $60.79 $444 - $486	-8 Reduced 0.01%	73,920 $4.44 Million
Q2 2021 Aug 19, 2021	BUY	$48.42 - $60.18 $664,273 - $825,609	13,719 Added 22.79%	73,928 $4.19 Million
Q1 2021 May 11, 2021	BUY	$47.16 - $54.44 $989,746 - $1.14 Million	20,987 Added 53.51%	60,209 $3.19 Million
Q4 2020 Feb 09, 2021	BUY	$48.52 - $58.02 $78,311 - $93,644	1,614 Added 4.29%	39,222 $1.98 Million
Q3 2020 Dec 18, 2020	BUY	$53.07 - $61.1 $4,723 - $5,437	89 Added 0.24%	37,608 $2.14 Million
Q2 2020 Aug 19, 2020	SELL	$43.1 - $55.31 $220,197 - $282,578	-5,109 Reduced 11.99%	37,519 $2.09 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $77,280 - $104,969	2,045 Added 5.04%	42,628 $2.28 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $256,161 - $304,425	-6,033 Reduced 12.94%	40,583 $2.01 Million
Q3 2019 Nov 15, 2019	SELL	$40.12 - $45.47 $1.05 Million - $1.19 Million	-26,260 Reduced 36.03%	46,616 $2.23 Million
Q2 2019 Aug 19, 2019	BUY	$37.28 - $41.68 $788,919 - $882,032	21,162 Added 40.92%	72,876 $3.27 Million
Q1 2019 May 16, 2019	BUY	$35.49 - $43.02 $48,443 - $58,722	1,365 Added 2.71%	51,714 $1.95 Million
Q4 2018 Feb 20, 2019	BUY	$36.86 - $41.49 $591,639 - $665,955	16,051 Added 46.8%	50,349 $2.06 Million
Q3 2018 Nov 21, 2018	SELL	$34.76 - $39.72 $736,633 - $841,746	-21,192 Reduced 38.19%	34,298 $1.38 Million
Q2 2018 Aug 16, 2018	BUY	$34.55 - $37.05 $611,845 - $656,118	17,709 Added 46.87%	55,490 $1.95 Million
Q1 2018 May 16, 2018	BUY	$32.97 - $36.63 $1.25 Million - $1.38 Million	37,781 New	37,781 $1.32 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Plan Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Plan Partners, LLC with notifications on news.

Account